BioSpace News Archive

VBL Therapeutics, reminds its shareholders to vote in favor of the previously announced proposed merger with Notable Labs at the annual and special meeting for shareholders of record as of September 5, 2023.

AbbVie (NYSE: ABBV) will announce its third-quarter 2023 financial results on Friday, October 27, 2023, before the market opens.

Promontory Therapeutics Inc. will present a poster on lead therapeutic candidate, PT-112, and its early molecular effects culminate in immunogenic cancer cell death (ICD), at the American Association for Cancer Research (AACR) – National Cancer Institute (NCI) – European Organisation for Research and Treatment of Cancer (EORTC) International Conference on Molecular Targets and Cancer Therapeutics. The AACR-NCI-EORTC “ENA Triple Conference” will be held from October 11-15, 2023 in Boston.

Autobahn Therapeutics today announced that Kevin Finney, President and Chief Executive Officer, will present at the following upcoming investor conferences.

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the signing of two new strategic partnership agreements with the country’s leading endodontic dental service organizations (DSOs) to expand patient access to a best-in-class root canal experience.

Alpine Immune Sciences, Inc. today announced the appointment of Wolfgang Dummer, M.D., Ph.D., to Chief Medical Officer effective October 2, 2023.

Inhibikase Therapeutics, Inc. today announced that risvodetinib (IkT-148009) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Multiple System Atrophy (MSA).

Day Zero Diagnostics Inc. announced today the addition of Patricia (Trish) Simner , Ph.D., M.Sc., to its clinical advisory board.

BIOXYTRAN, INC. announced that Bioxtran CCO Michael Sheikh will be giving a presentation about the company’s small pharma strategy on the Emerging Growth Conference on October 5, 2023 at 10:15 am EST.

IFF’s Pharma Solutions division is poised to showcase its extensive portfolio of leading excipients and present proprietary research that will address pivotal formulation challenges, and spotlight new innovation possibilities at AAPS 2023 PharmSci 360 in Orlando, Florida at booth 2242.